rac-Balanol
| Internal ID | 1a33d6ff-c263-4477-aea5-f2a872b6081b |
| Taxonomy | Benzenoids > Benzene and substituted derivatives > Benzophenones |
| IUPAC Name | 2-[2,6-dihydroxy-4-[3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C28H26N2O10/c31-16-8-6-14(7-9-16)26(36)30-18-13-29-10-2-5-22(18)40-28(39)15-11-20(33)24(21(34)12-15)25(35)23-17(27(37)38)3-1-4-19(23)32/h1,3-4,6-9,11-12,18,22,29,31-34H,2,5,10,13H2,(H,30,36)(H,37,38) |
| InChI Key | XYUFCXJZFZPEJD-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C28H26N2O10 |
| Molecular Weight | 550.50 g/mol |
| Exact Mass | 550.15874503 g/mol |
| Topological Polar Surface Area (TPSA) | 203.00 Ų |
| XlogP | 0.70 |
| Atomic LogP (AlogP) | 2.15 |
| H-Bond Acceptor | 10 |
| H-Bond Donor | 7 |
| Rotatable Bonds | 7 |
| rac-Balanol |
| Ophiocordin;Azepinostatin |
| 167937-47-5 |
| BDBM3182 |
| SCHEMBL12012990 |
| ICX5609002 |
| FT-0662471 |
| 2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]azepan-4-yl}oxy)carbonyl]phenyl}carbonyl)-3-hydroxybenzoic acid |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5352 | 53.52% |
| Caco-2 | - | 0.9113 | 91.13% |
| Blood Brain Barrier | - | 0.7750 | 77.50% |
| Human oral bioavailability | - | 0.6286 | 62.86% |
| Subcellular localzation | Mitochondria | 0.4927 | 49.27% |
| OATP2B1 inhibitior | - | 0.5698 | 56.98% |
| OATP1B1 inhibitior | + | 0.8566 | 85.66% |
| OATP1B3 inhibitior | + | 0.9344 | 93.44% |
| MATE1 inhibitior | - | 0.9000 | 90.00% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | - | 0.5093 | 50.93% |
| P-glycoprotein inhibitior | + | 0.7310 | 73.10% |
| P-glycoprotein substrate | + | 0.6331 | 63.31% |
| CYP3A4 substrate | + | 0.5941 | 59.41% |
| CYP2C9 substrate | - | 0.8067 | 80.67% |
| CYP2D6 substrate | - | 0.8159 | 81.59% |
| CYP3A4 inhibition | - | 0.9131 | 91.31% |
| CYP2C9 inhibition | - | 0.9014 | 90.14% |
| CYP2C19 inhibition | - | 0.8601 | 86.01% |
| CYP2D6 inhibition | - | 0.8772 | 87.72% |
| CYP1A2 inhibition | - | 0.8003 | 80.03% |
| CYP2C8 inhibition | + | 0.8267 | 82.67% |
| CYP inhibitory promiscuity | - | 0.9669 | 96.69% |
| UGT catelyzed | + | 0.9000 | 90.00% |
| Carcinogenicity (binary) | - | 0.9000 | 90.00% |
| Carcinogenicity (trinary) | Non-required | 0.7450 | 74.50% |
| Eye corrosion | - | 0.9890 | 98.90% |
| Eye irritation | - | 0.9198 | 91.98% |
| Skin irritation | - | 0.7639 | 76.39% |
| Skin corrosion | - | 0.9440 | 94.40% |
| Ames mutagenesis | - | 0.6800 | 68.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3925 | 39.25% |
| Micronuclear | + | 0.7500 | 75.00% |
| Hepatotoxicity | + | 0.5125 | 51.25% |
| skin sensitisation | - | 0.8991 | 89.91% |
| Respiratory toxicity | + | 0.6444 | 64.44% |
| Reproductive toxicity | + | 0.8889 | 88.89% |
| Mitochondrial toxicity | + | 0.8375 | 83.75% |
| Nephrotoxicity | - | 0.5829 | 58.29% |
| Acute Oral Toxicity (c) | III | 0.6645 | 66.45% |
| Estrogen receptor binding | + | 0.6712 | 67.12% |
| Androgen receptor binding | + | 0.8351 | 83.51% |
| Thyroid receptor binding | - | 0.5865 | 58.65% |
| Glucocorticoid receptor binding | - | 0.5078 | 50.78% |
| Aromatase binding | - | 0.5292 | 52.92% |
| PPAR gamma | + | 0.7209 | 72.09% |
| Honey bee toxicity | - | 0.8458 | 84.58% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.6000 | 60.00% |
| Fish aquatic toxicity | + | 0.6712 | 67.12% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit |
3.9 nM |
Kd |
via Super-PRED
|
| CHEMBL4273 | Q13976 | cGMP-dependent protein kinase 1 beta |
1.6 nM |
Kd |
via Super-PRED
|
| CHEMBL299 | P17252 | Protein kinase C alpha |
74 nM 6.4 nM 370 nM 30 nM |
IC50 Kd IC50 IC50 |
via Super-PRED
via Super-PRED via Super-PRED via Super-PRED |
| CHEMBL3045 | P05771 | Protein kinase C beta |
10 nM 500 nM 10 nM 1.8 nM 32 nM |
IC50 IC50 IC50 Kd IC50 |
via Super-PRED
via Super-PRED via Super-PRED via Super-PRED via Super-PRED |
| CHEMBL2996 | Q05655 | Protein kinase C delta |
420 nM 16 nM 4 nM 32 nM 30 nM |
IC50 IC50 IC50 IC50 IC50 |
via Super-PRED
via Super-PRED via Super-PRED via Super-PRED via Super-PRED |
| CHEMBL3582 | Q02156 | Protein kinase C epsilon |
10 nM 340 nM 49 nM 49 nM |
IC50 IC50 IC50 IC50 |
via Super-PRED
via Super-PRED via Super-PRED via Super-PRED |
| CHEMBL3616 | P24723 | Protein kinase C eta |
22 nM 100 nM 20 nM 3 nM 260 nM |
IC50 IC50 IC50 IC50 IC50 |
via Super-PRED
via Super-PRED via Super-PRED via Super-PRED via Super-PRED |
| CHEMBL2938 | P05129 | Protein kinase C gamma |
400 nM 30 nM 34 nM 10 nM 10 nM |
IC50 IC50 IC50 IC50 IC50 |
via Super-PRED
via Super-PRED via Super-PRED via Super-PRED via Super-PRED |
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.83% | 97.09% |
| CHEMBL3194 | P02766 | Transthyretin | 94.93% | 90.71% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.51% | 91.11% |
| CHEMBL2581 | P07339 | Cathepsin D | 92.20% | 98.95% |
| CHEMBL3475 | P05121 | Plasminogen activator inhibitor-1 | 91.03% | 83.00% |
| CHEMBL2535 | P11166 | Glucose transporter | 90.66% | 98.75% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 90.57% | 93.03% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 89.79% | 96.09% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 88.27% | 95.89% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 87.97% | 91.19% |
| CHEMBL2782 | P35610 | Acyl coenzyme A:cholesterol acyltransferase 1 | 87.36% | 91.65% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 86.95% | 99.23% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.82% | 93.56% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 86.71% | 93.99% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 86.54% | 99.17% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 84.91% | 90.20% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 84.18% | 95.58% |
| CHEMBL1293277 | O15118 | Niemann-Pick C1 protein | 83.63% | 81.11% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 83.48% | 95.56% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 82.73% | 85.31% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 81.59% | 91.07% |
| CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 | 81.39% | 97.03% |
| CHEMBL228 | P31645 | Serotonin transporter | 81.39% | 95.51% |
| CHEMBL241 | Q14432 | Phosphodiesterase 3A | 80.50% | 92.94% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 2290 |
| LOTUS | LTS0157481 |
| wikiData | Q104201468 |